Author

Raj Jayanthan

Observed names: Raj K Jayanthan, Raj K. Jayanthan

Observed institutions: Meharry Medical College, Montefiore Medical Center, Baylor College of Medicine, Texas Children's Hospital

ORCID: 0000-0003-3262-3328

Observed ORCID: 0000-0003-3262-3328

OpenAlex ID: A5023745617

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

2017 · David C. Fajgenbaum, Thomas S. Uldrick, et al. · Blood · 652

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

2018 · Frits van Rhee, Peter Voorhees, et al. · Blood · 430

Castleman disease

2021 · Antonino Carbone, Margaret Borok, et al. · Nature Reviews Disease Primers · 207

ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder

2020 · Sheila K. Pierson, Johnson S. Khor, et al. · Cell Reports Medicine · 34

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

2020 · David C. Fajgenbaum, David Wu, et al. · American Journal of Hematology · 33

Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research.

2015 · Samantha Kass Newman, Raj K Jayanthan, et al. · PubMed · 6

Rare disease research requires (and benefits from) global collaboration: three examples from the Castleman Disease Collaborative Network

2016 · Hayley Williamson, Grant Mitchell, et al. · Revista de Medicina

Works count: 7

Citation count: 1,362

H-index: 6

I10-index: 5